Lucid Diagnostics Releases Positive Data from First Prospective Clinical Utility Study of EsoGuard® Esophageal Precancer Detection

Multicenter observational study documents excellent concordance of EsoGuard results with subsequent medical decision-making by multiple physicians
NEW YORK, Sept. 7, 2023 /PRNewswire/ -- Lucid...

Related Keywords

Lishan Aklog ,Nasdaq ,Pavmed Inc ,Exchange Commission ,Lucid Diagnostics Inc ,Lucid Diagnostics ,Clinical Utility Study ,Samples Collected ,Triage Test ,Identify Barrett ,Interim Data ,Senior Vice President ,Chief Medical Officer ,Cell Collection Device ,Chief Executive ,Esophageal Cell Collection Device ,Annual Report ,Quarterly Report ,Markets ,